# Junta clínica — PT-pseudo_f4ea752ca1bb (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_f4ea752ca1bb",
  "pid": "PT-pseudo_f4ea752ca1bb",
  "task": 1,
  "psa": 6.9,
  "age": 79,
  "months": 1,
  "pirads": "4",
  "psad": 0.159,
  "psav": 1.53,
  "psap": 6.6,
  "vol": 43.34,
  "dre": "Nodus",
  "bx": "None",
  "cspca": 0.7682602,
  "medhx": "COPD",
  "meds": "tiotropium, salbutamol PRN",
  "notes": "PSA 6.9 ng/mL. PI-RADS 4. PSAD 0.16. Prostate volume 43 mL. DRE nodus. csPCa 0.77.",
  "pmhx": [
    "COPD"
  ],
  "allergies": [],
  "vitals": {
    "weight": "84 kg",
    "height": "188 cm",
    "bmi": "23.8",
    "bp": "125/84 mmHg",
    "hr": "75 bpm",
    "smoking": "Current smoker (15 pack-yr)",
    "last_dental": "3 yr ago",
    "flu_vax": "Nov 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "21 Jan 2025",
  "enc_ref": "Dr. F. de Boer (GP)",
  "enc_type": "Follow-up - PSA + MRI",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Persistent elevation of the prostate-specific antigen level to 6.9 ng/mL prompted this consultation after recent multiparametric imaging."
    },
    {
      "s": "History",
      "t": "A 79-year-old retired civil servant entered the system in spring 2023 after an initial prostate-specific antigen reading of 3.7 ng/mL. Surveillance has continued given the steady upward trend. Following the passing of his spouse several years prior, he now resides solo, depending on his daughter for mail handling while maintaining full independence in daily routines. Lower urinary tract complaints remain slight, reflected by an IPSS score of 3. Respiratory management involves tiotropium alongside salbutamol administered as required for his COPD. Beyond urological matters, he recently finished a standard colonoscopy screening and visited vascular surgery regarding asymptomatic varicose veins. Daily gardening sustains his activity level, he completely avoids alcohol, and maintains a current smoking status with a 15 pack-year history. He explicitly denies haematuria, unexplained weight loss, or bone pain."
    },
    {
      "s": "Physical examination",
      "t": "DRE — texture: firm, mobility: fixed, asymmetry: prominent. A discrete nodule resides within the right posterior peripheral zone, accompanied by overall gland enlargement. General assessment shows clear lung fields and a regular cardiac rhythm. Blood pressure registers at 125/84 mmHg, with a heart rate of 75 bpm."
    }
  ],
  "occupation": "retired civil servant",
  "marital": "Widowed",
  "living": "Lives alone",
  "next_of_kin": "Spouse / partner (primary contact)",
  "recent_other": [
    "Gastroenterology — surveillance colonoscopy",
    "Vascular surgery — varicose veins consult"
  ],
  "alcohol": "0 units / week (alcohol-free)",
  "exercise": "Gardening, no structured exercise",
  "ipss": "IPSS score: 3/35 (mild LUTS)",
  "admin": "Daughter manages communication; CC on letters with patient consent.",
  "mri_hospital": "Ziekenhuis Gelderse Vallei (Ede)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_f4ea752ca1bb
Task: 1

Encounter: Urology - outpatient on 21 Jan 2025.
Referrer: Dr. F. de Boer (GP).
Type: Follow-up - PSA + MRI.

Clinical data (read-only — values loaded from the record):
  - 79-year-old male
  - PSA: 6.9 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.159 ng/mL²
  - PSA velocity: 1.53 ng/mL/yr
  - Prior PSA: 6.6 ng/mL
  - Prostate volume: 43.34 mL
  - Months since last PSA: 1
  - DRE findings: Nodus (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: None (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.7682602 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: COPD
  - Problem list / PMHx: COPD
  - Current medication: tiotropium, salbutamol PRN
  - Allergies: NKA
  - Additional notes: PSA 6.9 ng/mL. PI-RADS 4. PSAD 0.16. Prostate volume 43 mL. DRE nodus. csPCa 0.77.

Vitals: weight 84 kg, height 188 cm, BMI 23.8, BP 125/84 mmHg, HR 75 bpm. Smoking: Current smoker (15 pack-yr).

Chief complaint: Persistent elevation of the prostate-specific antigen level to 6.9 ng/mL prompted this consultation after recent multiparametric imaging.

History: A 79-year-old retired civil servant entered the system in spring 2023 after an initial prostate-specific antigen reading of 3.7 ng/mL. Surveillance has continued given the steady upward trend. Following the passing of his spouse several years prior, he now resides solo, depending on his daughter for mail handling while maintaining full independence in daily routines. Lower urinary tract complaints remain slight, reflected by an IPSS score of 3. Respiratory management involves tiotropium alongside salbutamol administered as required for his COPD. Beyond urological matters, he recently finished a standard colonoscopy screening and visited vascular surgery regarding asymptomatic varicose veins. Daily gardening sustains his activity level, he completely avoids alcohol, and maintains a current smoking status with a 15 pack-year history. He explicitly denies haematuria, unexplained weight loss, or bone pain.

Physical examination: DRE — texture: firm, mobility: fixed, asymmetry: prominent. A discrete nodule resides within the right posterior peripheral zone, accompanied by overall gland enlargement. General assessment shows clear lung fields and a regular cardiac rhythm. Blood pressure registers at 125/84 mmHg, with a heart rate of 75 bpm.

Patient info: retired civil servant; Widowed; Lives alone.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 0 units / week (alcohol-free); exercise Gardening, no structured exercise; IPSS score: 3/35 (mild LUTS).

Recent other appointments: Gastroenterology — surveillance colonoscopy; Vascular surgery — varicose veins consult.
Admin: Daughter manages communication; CC on letters with patient consent.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.68
  uncertainty  +/- 0.08 epistemic (95% band 0.52-0.85); among patients I cannot tell apart the outcome was 0.90 of 1.00 mixed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = None (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = 1 on the problem list (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 79 (2% of my signal; from age) · DRE = Nodus (10% of my signal; from dre_suspicious) · PSA = 6.9 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 43.34 mL (1% of my signal; from log_vol, vol) · PSA density = 0.159 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.77 (1% of my signal; from cspca) · PI-RADS = 4 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: clear — 'firm' tier; out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: never biopsied. My criterion answers BIOPSY.

The criterion: sample when the mpMRI shows a PI-RADS 3 or higher lesion; defer at PI-RADS 1-2. In the labelled series this criterion matched the reading urologist in 24 of 24 cases in exactly this situation.

Like Expert 1, I have read ONLY the visible panel — not the mpMRI prose, the PSA trajectory, the
previous notes or the laboratory panel. Departing from me needs a specific finding from a document
somebody actually opened, named out loud; not a restatement of the panel numbers I already used.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  decisive   PI-RADS = 4
  important  prior biopsy = None
  noted      age = 79 · DRE = Nodus · PSA = 6.9 ng/mL · prostate volume = 43.34 mL · PSA density = 0.159 · comorbidity = 1 on the problem list
  not used   family history, csPCa probability
CONFIDENCE: clear — the rule matched the reading urologist in 24 of 24 labelled cases

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 24 labelled men in this same situation (None prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 1.88: PI-RADS 5, PSA 7.6, PSAD 0.236, age 78, DRE Nodus -> BIOPSY (borderline). He wrote: "This is borderline. A P5 but old man and moderately PSA with no symptoms."
  2. distance 2.16: PI-RADS 4, PSA 4.8, PSAD 0.086, age 65, DRE Nodus -> BIOPSY (clear). He wrote: "P4 in patient 65 years."
  3. distance 2.56: PI-RADS 4, PSA 9.3, PSAD 0.296, age 66, DRE Normal -> BIOPSY (clear). He wrote: "P4 in 66 year old patient."

PRECEDENT: BIOPSY (weighted vote 1.00 for biopsy). Distance-weighted precedent is strong here (0.92 leave-one-out).

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  decisive   PI-RADS = 4
  important  age = 79 · PSA = 6.9 ng/mL
  noted      prior biopsy = None · family history = not opened (0 of 91) · DRE = Nodus · prostate volume = 43.34 mL · PSA density = 0.159
  not used   csPCa probability, comorbidity
CONFIDENCE: clear — the precedents agree (1.00) and the library is right 92% of the time in this situation out of fold

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 24 labelled traces in this situation (None prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  decisive   PI-RADS = 4
  important  age = 79 · DRE = Nodus · PSA = 6.9 ng/mL
  noted      prior biopsy = None · family history = not opened (0 of 91) · prostate volume = 43.34 mL · PSA density = 0.159 · comorbidity = 1 on the problem list
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
"a PI-RADS threshold of $\\ge 3$ is used to trigger biopsy [135, 226, 264, 375], at the cost of missing a small number of mainly ISUP GG 2 cancers, especially in biopsy-naïve patients or in highly selected populations with high prevalence of csPCa (in which the MRI NPV decreases) [372, 472]."
This guideline suggests that a PI-RADS threshold of $\\ge 3$ should trigger a biopsy, even though it may miss some low-grade cancer.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, I see that the guideline treats the PI-RADS score as a primary trigger, whereas EXPERT-STRUCTURED marked prior biopsy = None as decisive, which the guideline treats as context. The guideline requires a comparison MRI or a due confirmatory biopsy to be established, which is a fact the panel does not represent.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the prior biopsy: at None the guideline suggests a biopsy is triggered by PI-RADS $\\ge 3$, not the prior biopsy status itself.
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - the PSA velocity: the guideline does not explicitly state a threshold for PSA velocity, but the patient's velocity of 1.53 ng/mL/yr is a fact the guideline needs to contextualize.
laboratory_results - the PSA density: the guideline suggests a PSA-D cut-off of 0.15 ng/mL/cc may guide the decision.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges on whether the PI-RADS 4 finding, combined with the lack of prior biopsy, is sufficient to trigger a biopsy according to the EAU guidelines.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Does the mpMRI prose indicate whether the lesion is compared against an earlier study?
  psa_trend (get_psa_trend) -> How does the PSA velocity of 1.53 ng/mL/yr fit into the context of the EAU guideline?
  previous_notes (get_previous_notes) -> What is the management context regarding the prior biopsy status?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the status of the lesion comparison in the radiology_report?
  Q2. How should the PSA velocity of 1.53 ng/mL/yr be contextualized against the EAU guideline?
  Q3. What is the management context regarding the prior biopsy status in the previous_notes?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
Subject: Multiparametric MRI of the Prostate | Date: 15 January 2025 | Facility: Ziekenhuis Gelderse Vallei (Ede)
COMPARISON: new
LESION: PI-RADS 4 lesion in the right posterior peripheral zone.

psa_trend
PSA 2.0 (Apr 2023) rising to 6.9 (Jan 2025), steepest in the last year.

previous_notes
PRIOR GRADE: not recorded
BIOPSY SESSIONS: None
SURVEILLANCE: Surveillance has continued given the steady upward trend.
TREATMENT: none recorded

WHAT I DID NOT OPEN
family-history anamnesis, because it was not listed in the plan and its absence does not change the immediate decision based on the opened documents.

WHAT THIS SUPPORTS
FOR sampling this patient now
PI-RADS 4 finding supports biopsy as per EXPERT-COHORT rule.
The PSA velocity of 1.53 ng/mL/yr is a fact the EAU guideline needs to contextualize.

AGAINST sampling this patient now
nothing

WHERE THIS LEANS
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 6.90 ng/mL over 4 points spanning 21 months; velocity +2.79 ng/mL per year; doubling time about 12 months.
PROJECTION at 6 months: 10.3 ng/mL, conformal 95% band 3.0-36.1.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 6.9 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.63
  uncertainty  +/- 0.10 epistemic (95% band 0.43-0.84), of which 0.01 comes from values that had to be imputed
  reliability  MODERATE ('supports' tier) — out-of-fold it was right 56% of the time over the 25 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = None (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 4 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      PSA = 6.9 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 43.34 mL (4% of my signal; from log_vol, vol) · PSA density = 0.159 (0% of my signal; from psad_calc) · comorbidity = 1 on the problem list (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, DRE, csPCa probability
CONFIDENCE: borderline — 'supports' tier; out-of-fold it was right 56% of the time over the 25 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.68  ('firm' tier; weight 3.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.63  ('supports' tier, fusion_nolab; weight 3.0)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=1.00  (k=3 precedents; does not vote)
  EXPERT-COHORT      BIOPSY  (rule pirads_ge_3; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: cohort criterion (pirads_ge_3) — carried by EXPERT-COHORT.
PANEL ANSWER: BIOPSY. It matched the reading urologist in 24 of 24 labelled cases in exactly this situation (never biopsied).

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           None                         E1:DEC E3:DEC cohort:IMP library:not E2:—            -> noted
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          79                           E1:not E3:— cohort:not library:IMP E2:—              -> important
  dre          Nodus                        E1:not E3:— cohort:not library:not E2:—              -> not_used (raised from important by the board)
  psa          6.9 ng/mL                    E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          43.34 mL                     E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.159                        E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.77                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       4                            E1:not E3:IMP cohort:DEC library:DEC E2:—            -> decisive
  comorbidity  1 on the problem list        E1:IMP E3:not cohort:not library:— E2:—              -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: clear.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes) appear to answer the moderator's questions, as the trace model listed these documents, and they were all retrieved.

ALIGNMENT WITH THE PANEL
The retrieved evidence supports the PANEL-PROTOCOL's answer of BIOPSY, as the cohort criterion (PI-RADS $\ge 3$) fired, which is the rule that led to the panel's decision.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the status of the lesion comparison in the radiology_report? The report states "COMPARISON: new," which addresses this.
Q2. How should the PSA velocity of 1.53 ng/mL/yr be contextualized against the EAU guideline? The EAU expert noted this fact needs contextualization.
Q3. What is the management context regarding the prior biopsy status in the previous_notes? The notes state "BIOPSY SESSIONS: None," addressing this.

WHAT CARRIES WEIGHT, AND WHY
<pirads>: decisive: 4 (from EXPERT-COHORT rule pirads_ge_3; this is the rule that fired)
<prior biopsy>: decisive: None (from EXPERT-STRUCTURED and EXPERT-COHORT rule)
<psa>: important: 6.9 ng/mL (from EXPERT-STRUCTURED and EXPERT-TRACE)
<psa_trend>: important: rising (from EXPERT-PSA)
I agree with the PANEL-PROTOCOL's weighting, as the cohort criterion is a strong, rule-based trigger. My confidence in the record as it stands is clear, as the necessary documents were retrieved to address the open questions.

MY SUGGESTION TO THE CHAIR
I suggest proceeding with a biopsy based on the clear trigger from the cohort criterion (PI-RADS 4) and the lack of prior biopsy, as supported by the panel protocol.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

79 y/o male, biopsy-naive, PI-RADS 4 lesion with PSA density 0.159 warrants biopsy. Prior grade not recorded, but the new PI-RADS 4 finding is the driver. No conflicting data exists to defer sampling.

What carried weight: bx=noted, age=important, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes
